Skip to content

Ketamine research published in 2024

Page 18 of 26: studies 341 to 360 of 518, newest first. Back to the ketamine overview

Studies

Protocol for a randomised controlled trial of ketamine versus ketamine and behavioural activation therapy for adults with treatment-resistant depression in the community.

BMJ Open May 1, 2024 Ben Beaglehole, Richard Porter, Katie M. Douglas et al. 5 citations

Although short-term benefits follow parenteral ketamine for treatment-resistant major depressive disorder (TR-MDD), there are challenges that prevent routine use of ketamine by clinicians. These include acute dissociative effects of parenteral ketamine, high relapse rates following ketamine dosing and the uncertain role of psychotherapy. This randomised controlled trial (RCT) seeks to establish...

DOI: 10.1136/bmjopen-2024-084844 (opens in new tab) Full text (opens in new tab) Adult psychiatry Psychosocial intervention Depression treatment Ketamine therapy +2

Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature.

Journal of Psychiatric Practice May 1, 2024 Aniruddha Deka, Emmanuel Joseph, Neha Sharma et al. 3 citations

Serotonin (5-HT) syndrome (SS) consists of changes in mental status as well as autonomic and neuromuscular changes. Though not well understood, serotonergic pathways have been implicated in the mechanism of action of electroconvulsive therapy (ECT). Ketamine has been used as an induction agent in ECT and as therapy for treatment-resistant depression. Utilizing a case report and literature...

DOI: 10.1097/PRA.0000000000000787 (opens in new tab) Full text (opens in new tab) Depression treatment Drug interactions Serotonin syndrome Patient safety +1

A Case of Stress-Induced Cardiomyopathy After Ketamine Infusion.

Cureus May 1, 2024 Zach Hart, Thomas Anderson, Hanna Fanous et al. 2 citations

We report the case of a 64-year-old female with a history of hypothyroidism and isolated parotid sarcoidosis who presented with acute-onset chest pain and dyspnea. Echocardiogram demonstrated transiently reduced ejection fraction with apical hypokinesis, without evidence of obstructive coronary lesions on angiography, compatible with stress-induced cardiomyopathy. She received a ketamine...

DOI: 10.7759/cureus.59709 (opens in new tab) Full text (opens in new tab) Cardiac Imaging-MRI Catecholamine-induced myocardial toxicity Iv ketamine Stress induced cardiomyopathy +3

Effects of ketamine on the severity of depression and anxiety following postoperative mechanical ventilation: a single-blind randomized clinical trial in Iran.

Acute and critical care May 1, 2024 Seyedbabak Mojaveraghili, Fatemeh Talebi, Sima Ghorbanoghli et al. 1 citation

In this study, we compare the effects of ketamine and the combination of midazolam and morphine on the severity of depression and anxiety in mechanically ventilated patients after discharge from the intensive care unit (ICU). This randomized single-blind clinical trial included 50 patients who were candidates for craniotomy and postoperative mechanical ventilation in the ICU of 5 Azar Teaching...

Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential.

Aging and disease April 29, 2024 Qianting Deng, Emily Parker, Chongyun Wu et al. 8 citations

Depression represents a prevalent and enduring mental disorder of significant concern within the clinical domain. Extensive research indicates that depression is very complex, with many interconnected pathways involved. Most research related to depression focuses on monoamines, neurotrophic factors, the hypothalamic-pituitary-adrenal axis, tryptophan metabolism, energy metabolism, mitochondrial...

DOI: 10.14336/AD.2024.0239 (opens in new tab) Full text (opens in new tab) Mental health Depression treatment Ketamine therapy Antidepressants

A retrospective analysis of iv ketamine outcome on hospitalisations in an unselected psychiatric sample.

Acta Neuropsychiatrica April 25, 2024 Karl Sandström, Olli Kampman, Peter Asellus 1 citation

This study aims to explore the outcome with iv ketamine treatment in a real-world clinical setting, primarily measured as posttreatment days hospitalised. The psychiatric medical records of 46 patients having received iv ketamine on a psychiatric treatment indication between 2015 and 2018 were retrospectively examined. Analysis comparing the number and duration of hospital admissions before and...

Ketamine and its enantiomers for depression: a bibliometric analysis from 2000 to 2023.

European Archives of Psychiatry and Clinical Neuroscience April 25, 2024 Li-Yuan Zhao, Guang-Fen Zhang, Xue-Jie Lou et al. 11 citations

Ketamine has demonstrated rapid and sustained antidepressant effects, marking its emergence as an innovative treatment of depression. Despite the growing number of preclinical and clinical studies exploring the antidepressant effects of ketamine and its enantiomers, a comprehensive bibliometric analysis in this field has yet to be conducted. This study employs bibliometric methods and...

Effects of a single subanesthetic dose of esketamine on postoperative subthreshold depressive symptoms in patients undergoing unilateral modified radical mastectomy: a randomised, controlled, double-blind trial.

BMC Psychiatry April 24, 2024 Huanwei Wang, Rigen Te, Jianxing Zhang et al. 15 citations

Breast cancer is the most common malignant tumor in females worldwide. During disease development, breast cancer patients suffer anxious and depressed, which may lead to worse quality of life or even higher mortality. Esketamine has been regarded as an antidepressant in breast cancer patients with mild or moderate depression. Here, we wonder whether the administration of esketamine could reduce...

A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder.

The Journal of Clinical Psychiatry April 24, 2024 Gregory H Jones, Courtney M Vecera, Ana C Ruiz et al. 13 citations

Objective: Although individuals with a family history of alcohol use disorder (AUD) have a superior antidepressant response to ketamine, outcomes in patients with current AUD remain unclear. This study sought to investigate whether intranasal (IN) racemic (R,S)-ketamine had antisuicidal and antidepressant effects in unipolar and bipolar depression and whether comorbid AUD conferred superior...

DOI: 10.4088/JCP.23m14974 (opens in new tab) Full text (opens in new tab) Depression Ketamine therapy Mental health treatment Substance abuse +1

Neural assemblies coordinated by cortical waves are associated with waking and hallucinatory brain states.

Cell Reports April 23, 2024 Adeeti Aggarwal, Jennifer Luo, Helen Chung et al. 17 citations

The relationship between sensory stimuli and perceptions is brain-state dependent: in wakefulness, suprathreshold stimuli evoke perceptions; under anesthesia, perceptions are abolished; and during dreaming and in dissociated states, percepts are internally generated. Here, we exploit this state dependence to identify brain activity associated with internally generated or stimulus-evoked...

Evaluation of Ketamine after subacute low dosage Lipopolysaccharide-activated Microglia produced depressive-like phenotype in mice

Research Journal of Pharmacy and Technology April 22, 2024 Shuvranshu Praharaj, Vandurayanpet Kaliyamoorthy Kalaichelvan, Vedigounder Murugan et al.

Depression is a common mental illness, with an estimated 3.8% of global population affected. Peripheral administration of lipopolysaccharide (LPS) culminate in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in the forced swim test (FST) and anhedonia in sucrose preference tests (SPT). After 6 days of LPS stimulation, we established a depression...

The Effect of Preprocedural Low-Dose Ketamine for Pain and Anxiety in Patients during Thoracic Epidural Catheterization.

Medicina (Kaunas, Lithuania) April 22, 2024 Onur Küçük, Esra Sarı, Musa Zengin et al. 2 citations

Background and Objectives: Thoracic epidural catheterization (TEC) can be both uncomfortable and fearful for patients when performed awake with the thought that the procedure may be painful. The aim of this study was to assess the effect of low-dose intravenous ketamine administration on pain and anxiety during the TEC procedure. Materials and Methods: Sixty patients were randomly divided into...

DOI: 10.3390/medicina60040679 (opens in new tab) Full text (opens in new tab) Ketamine Preprocedural low dose Thoracic epidural catheterization Pain management +4

Ketamine - precursor of a new generation antidepressant drugs

Farmacja Polska April 17, 2024 Jolanta B. Zawilska, Ewa Zwierzyńska 1 citation

Zaburzenia depresyjne są jednymi z najczęściej występujących chorób psychicznych na świecie. Leczenie depresji stanowi ważny problem medyczny, a strategie farmakologiczne oparte na wyrównywaniu zaburzeń transmisji monoaminergicznych w mózgu wiążą się z opóźnionym w czasie efektem przeciwdepresyjnym. Ponadto, coraz większy odsetek pacjentów cierpi na depresję lekooporną, gdzie pomimo wdrożenia...

DOI: 10.32383/farmpol/186596 (opens in new tab) Ampa receptor Nmda receptor Pharmacology

Ketamine induces multiple individually distinct whole-brain functional connectivity signatures.

Elife April 17, 2024 Flora Moujaes, Jie Lisa Ji, Masih Rahmati et al. 23 citations

Ketamine has emerged as one of the most promising therapies for treatment-resistant depression. However, inter-individual variability in response to ketamine is still not well understood and it is unclear how ketamine's molecular mechanisms connect to its neural and behavioral effects. We conducted a single-blind placebo-controlled study, with participants blinded to their treatment condition....

DOI: 10.7554/elife.84173 (opens in new tab) Full text (opens in new tab) Data reduction FMRI Gene expression Human +5

Cerebrospinal fluid metabolomes of treatment-resistant depression subtypes and ketamine response: a pilot study.

Discover Mental Health April 17, 2024 Jon Berner, Animesh Acharjee 7 citations

Depression is a disorder with variable presentation. Selecting treatments and dose-finding is, therefore, challenging and time-consuming. In addition, novel antidepressants such as ketamine have sparse optimization evidence. Insights obtained from metabolomics may improve the management of patients. The objective of this study was to determine whether compounds in the cerebrospinal fluid (CSF)...

DOI: 10.1007/s44192-024-00066-5 (opens in new tab) Full text (opens in new tab) Depression treatment Personalized medicine Mental health research Biomarkers

Psychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain: Protocol for a Pilot Randomized Controlled Trial.

JMIR Research Protocols April 17, 2024 Akash Goel, Bhavya Kapoor, Hillary Chan et al. 2 citations

Chronic pain affects approximately 8 million Canadians (~20%), impacting their physical and mental health while burdening the health care system with costs of upwards of US $60 billion a year. Indeed, patients are often trialed on numerous medications over several years without reductions to their symptoms. Therefore, there is an urgent need to identify new therapies for chronic pain to improve...

DOI: 10.2196/54406 (opens in new tab) Full text (opens in new tab) Psychedelic therapy 3-arm parallel group Cognitive behavior therapy Ketamine hydrochloride +8

Ketamine for major depressive disorder during an inpatient psychiatric admission: Effectiveness, adverse events, and lessons learned.

Journal of Affective Disorders April 15, 2024 Benjamin D. Brody, Nana Park, Alexander Christian et al. 8 citations

Most studies examining the efficacy of ketamine for Major Depressive Disorder (MDD) have been conducted in outpatient or mixed inpatient/outpatient settings. Less is known about effectiveness and tolerability of ketamine for psychiatrically hospitalized patients. Efficacy and tolerability data from a naturalistic sample of acute inpatients may help inform institutions considering ketamine...

Depression, an unmet health need in Africa: Understanding the promise of ketamine.

Heliyon April 15, 2024 Aletta Me Millen, William Mu Daniels, Sooraj Baijnath 6 citations

In Africa, there is currently a paucity of data on the epidemiology of depression, its treatment and management. The prevalence of depression is severely underestimated, with unique circumstances and societal risk factors associated with depression and its public awareness. Treating and managing depression is confounded by an inaccessibility to efficient and low-cost treatments for patients...

DOI: 10.1016/j.heliyon.2024.e28610 (opens in new tab) Full text (opens in new tab) Mechanism of action Mental health Psychopharmacology African healthcare +2

Recreational ketamine use can lead to irreversible bladder damage.

New Zealand Medical Journal April 12, 2024 Daniel Eaton, Frank Kueppers 1 citation

An increasing number of young patients with severe bladder overactivity syndrome potentially caused by recreational ketamine use has been treated in our department. Ketamine has become a popular and increasingly used recreational drug in New Zealand. Ketamine bladder syndrome has been reported internationally; however, local New Zealand data do not exist. It can lead to irreversible damage to...

DOI: 10.26635/6965.6357 (opens in new tab) Full text (opens in new tab) Ketamine abuse Bladder damage Drug complications Urinary dysfunction +1

Enhancing Cognitive Functions and Neuronal Growth through NPY1R Agonist and Ketamine Co-Administration: Evidence for NPY1R-TrkB Heteroreceptor Complexes in Rats.

Cells April 12, 2024 Carlos Arrabal-Gómez, Rasiel Beltran-Casanueva, Aracelis Hernández-García et al. 7 citations

This study investigates the combined effects of the neuropeptide Y Y1 receptor (NPY1R) agonist [Leu31-Pro34]NPY at a dose of 132 µg and Ketamine at 10 mg/Kg on cognitive functions and neuronal proliferation, against a backdrop where neurodegenerative diseases present an escalating challenge to global health systems. Utilizing male Sprague-Dawley rats in a physiological model, this research...

DOI: 10.3390/cells13080669 (opens in new tab) Full text (opens in new tab) Ketamine Npy1r agonist Npy1r-trkb heteroreceptor complex Cognitive functions +9